Buspirone Hydrochloride Tablet
Product Images NDC 71610-608

7 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71610-608). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 7.5 mg (71610 0608 60)

Bottle Label 7.5 mg (71610 0608 60)
Label for Buspirone Hydrochloride (Buspirone HCl) USP 7.5 mg oral tablets, containing 90 tablets per package. The label includes storage instructions and manufacturer information: Strides Pharma Science Ltd., Bangalore, India, with packaging by Aphena Pharma, Cookeville, TN. The label also displays the NDC 71610-0608-60 and batch/expiration data.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Structure (B0825ce2 82b8 4850 9e90 4259728823b5 01)

Structure (B0825ce2 82b8 4850 9e90 4259728823b5 01)
Chemical structure diagram of Buspirone Hydrochloride showing its molecular arrangement with multiple ring structures, nitrogen atoms, and an attached hydrochloride (HCl) moiety.*
FDA Label Image

5mg-dosage Adjustment (B0825ce2 82b8 4850 9e90 4259728823b5 02)

5mg-dosage Adjustment (B0825ce2 82b8 4850 9e90 4259728823b5 02)
An instructional diagram illustrating how to divide a 15 mg tablet of Buspirone Hydrochloride into smaller doses. It shows a 15 mg tablet divided into three parts labeled 5 mg each, indicating 15 mg (whole tablet), 10 mg (two-thirds of a tablet), 7.5 mg (half a tablet), and 5 mg (one-third of a tablet) dosing options.*
FDA Label Image

B0825ce2-82b8-4850-9e90-4259728823b5-03.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 03)

B0825ce2-82b8-4850-9e90-4259728823b5-03.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 03)
An instructional illustration showing a pair of hands holding a tablet gently between the thumb and forefinger, demonstrating how to hold or handle the tablet for oral administration.*
FDA Label Image

B0825ce2-82b8-4850-9e90-4259728823b5-04.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 04)

B0825ce2-82b8-4850-9e90-4259728823b5-04.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 04)
An instructional diagram illustrating tablet division to achieve different doses from a 30 mg tablet. It shows a whole tablet representing 30 mg, two-thirds of a tablet as 20 mg, half a tablet as 15 mg, and one-third of a tablet as 10 mg, visually represented by shaded segments of the tablet.*
FDA Label Image

B0825ce2-82b8-4850-9e90-4259728823b5-05.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 05)

B0825ce2-82b8-4850-9e90-4259728823b5-05.jpg (B0825ce2 82b8 4850 9e90 4259728823b5 05)
An instructional line drawing showing four fingers holding a tablet from both sides, illustrating how to properly hold or handle the tablet. The image is black and white with simplified outlines of fingers and the tablet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.